Company intelligence / Profile preview

AASA

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Aasa is a medical technology company focused on developing advanced point-of-care diagnostic solutions. The company's primary offering is a portable, rapid diagnostic platform designed to provide lab-quality results in minutes for a variety of clinical applications, including infectious diseases and cardiovascular markers. By integrating microfluidics with digital health capabilities, Aasa aims to decentralize testing and improve patient outcomes through immediate clinical decision-making. Their technology is particularly suited for use in emergency departments, primary care clinics, and resource-limited settings.

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: DeviceDiagnostic
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on AASA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AASA.

Explore the full profile